Swedbank AB Boosts Stake in Corteva, Inc. $CTVA

Swedbank AB raised its stake in shares of Corteva, Inc. (NYSE:CTVA) by 17.3% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,227,017 shares of the company’s stock after acquiring an additional 328,282 shares during the quarter. Swedbank AB owned approximately 0.33% of Corteva worth $186,424,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Harris Associates L P boosted its position in Corteva by 168.1% during the fourth quarter. Harris Associates L P now owns 17,026,221 shares of the company’s stock valued at $1,141,268,000 after purchasing an additional 10,675,052 shares in the last quarter. Norges Bank bought a new position in Corteva in the fourth quarter worth about $504,001,000. Northwestern Mutual Wealth Management Co. lifted its position in shares of Corteva by 6,527.4% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 3,148,212 shares of the company’s stock valued at $211,025,000 after buying an additional 3,100,709 shares during the last quarter. Perpetual Ltd lifted its position in shares of Corteva by 78,688.5% during the fourth quarter. Perpetual Ltd now owns 2,615,779 shares of the company’s stock valued at $175,336,000 after buying an additional 2,612,459 shares during the last quarter. Finally, Amundi boosted its holdings in shares of Corteva by 125.3% in the 3rd quarter. Amundi now owns 3,415,554 shares of the company’s stock valued at $219,620,000 after buying an additional 1,899,248 shares in the last quarter. 81.54% of the stock is owned by institutional investors.

Corteva Stock Performance

Shares of NYSE CTVA traded up $0.34 during mid-day trading on Tuesday, hitting $86.72. The stock had a trading volume of 535,288 shares, compared to its average volume of 4,018,642. The firm has a market cap of $58.00 billion, a PE ratio of 51.01, a PEG ratio of 2.62 and a beta of 0.56. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.03 and a current ratio of 1.47. The company has a 50 day moving average of $79.80 and a two-hundred day moving average of $76.94. Corteva, Inc. has a twelve month low of $60.53 and a twelve month high of $87.69.

Corteva (NYSE:CTVA) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, topping analysts’ consensus estimates of $1.18 by $0.32. The company had revenue of $4.91 billion during the quarter, compared to analysts’ expectations of $4.64 billion. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The firm’s revenue was up 11.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.13 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Research analysts predict that Corteva, Inc. will post 3.72 EPS for the current fiscal year.

Corteva Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, June 15th. Investors of record on Monday, June 1st were given a $0.18 dividend. The ex-dividend date was Monday, June 1st. This represents a $0.72 dividend on an annualized basis and a yield of 0.8%. Corteva’s dividend payout ratio is currently 42.35%.

Analyst Ratings Changes

CTVA has been the subject of several recent analyst reports. Morgan Stanley boosted their price objective on shares of Corteva from $84.00 to $95.00 and gave the stock an “overweight” rating in a research note on Thursday, May 28th. UBS Group cut their price target on shares of Corteva from $90.00 to $86.00 and set a “neutral” rating on the stock in a report on Tuesday, June 9th. Royal Bank Of Canada increased their price objective on Corteva from $95.00 to $97.00 and gave the company an “outperform” rating in a report on Thursday, May 7th. CICC Research raised their price objective on Corteva from $80.00 to $93.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 13th. Finally, Deutsche Bank Aktiengesellschaft upped their target price on Corteva from $90.00 to $100.00 in a research report on Monday, May 11th. Fourteen analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to MarketBeat.com, Corteva has a consensus rating of “Moderate Buy” and an average price target of $88.90.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.